Skip to main content

AD progresses in recent 10 years: from hypothesis to therapeutic targets

Guested edited by Weihong Song (Jining Medical University)

A thematic series in Translational Neurodegeneration

  1. Ageing is a crucial risk factor for Alzheimer’s disease (AD) and is characterised by systemic changes in both intracellular and extracellular microenvironments that affect the entire body instead of a single o...

    Authors: Yuqing Liu, Yejun Tan, Zheyu Zhang, Min Yi, Lemei Zhu and Weijun Peng
    Citation: Translational Neurodegeneration 2024 13:7
  2. Alzheimer's disease (AD) is a neurodegenerative disorder and the predominant type of dementia worldwide. It is characterized by the progressive and irreversible decline of cognitive functions. In addition to t...

    Authors: Min Zhang, Zhan Zhang, Honghong Li, Yuting Xia, Mengdan Xing, Chuan Xiao, Wenbao Cai, Lulu Bu, Yi Li, Tae-Eun Park, Yamei Tang, Xiaojing Ye and Wei-Jye Lin
    Citation: Translational Neurodegeneration 2024 13:1
  3. Alzheimer’s disease (AD) is a progressive neurodegenerative disease with phenotypic changes closely associated with both genetic variants and imaging pathology. Brain imaging biomarker genomics has been develo...

    Authors: Lanlan Li, Xianfeng Yu, Can Sheng, Xueyan Jiang, Qi Zhang, Ying Han and Jiehui Jiang
    Citation: Translational Neurodegeneration 2022 11:42
  4. Alzheimer’s disease (AD) is the most common neurodegenerative disease in the elderly worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the understanding of this disease, and may b...

    Authors: Chenghuan Song, Jiyun Shi, Pingao Zhang, Yongfang Zhang, Jianrong Xu, Lanxue Zhao, Rui Zhang, Hao Wang and Hongzhuan Chen
    Citation: Translational Neurodegeneration 2022 11:18